Decreased liver fatty Acid δ-6 and δ-5 desaturase activity in obese patients

Obesity

Volumn 18, Issue 7, 2010, Pages 1460-1463

  Araya, Julia ^a   Rodrigo, Ramón ^b   Pettinelli, Paulina ^b   Araya, A Verónica ^c   Poniachik, Jaime ^c   Videla, Luis A ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; DELTA 5 FATTY ACID DESATURASE; DELTA-5 FATTY ACID DESATURASE; LINOLEOYL COENZYME A DESATURASE; UNSATURATED FATTY ACID;

ADULT; ARTICLE; CHOLECYSTECTOMY; ENZYME ACTIVATION; ENZYMOLOGY; FATTY LIVER; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; METABOLISM; OBESITY; OXIDATIVE STRESS; PHYSIOLOGY; STOMACH BYPASS;

ADULT; CHOLECYSTECTOMY, LAPAROSCOPIC; ENZYME ACTIVATION; FATTY ACID DESATURASES; FATTY ACIDS, UNSATURATED; FATTY LIVER; FEMALE; GASTRIC BYPASS; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; LINOLEOYL-COA DESATURASE; LIPID METABOLISM; LIVER; MALE; OBESITY; OXIDATIVE STRESS;

EID: 77954143472     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.379     Document Type: Article

References (18)

1. Videla LA, Rodrigo R, Araya J, Poniachik J. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med 2006;12:555-558.
2. Aronis A, Madar Z, Tirosh O. Mechanism underlying oxidative stress-mediated lipotoxicity: exposure of J774.2 macrophages to triacylglycerols
3. facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radic Biol Med 2005;38:1221-1230.
4. Araya J, Rodrigo R, Videla LA et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci 2004;106:635-643.
5. Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 2005;7:1040-1052.
6. Clarke SD. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr Opin Lipidol 2004;15:13-18.
7. Matthews DR, Hosker J P, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
8. Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996;239:70-76.
9. Su HM, Brenna JT. Simultaneous measurement of desaturase activities using stable isotope tracers or a nontracer method. Anal Biochem 1998;261:43-50.
10. Nakamura MT, Nara TY. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu Rev Nutr 2004;24:345-376.
11. Elizondo A, Araya J, Rodrigo R et al. Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. Obesity (Silver Spring) 2007;15:24-31.
12. Borkman M, Storlien LH, Pan DA et al. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993;328:238-244.
13. Shimomura I, Bashmakov Y, Horton JD. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 1999;274:30028-30032.
14. Xu J, Teran-Garcia M, Park JH, Nakamura MT, Clarke SD. Polyunsaturated fatty acids suppress hepatic sterol regulatory element-binding protein-1 expression by accelerating transcript decay. J Biol Chem 2001;276: 9800-9807.
15. Videla LA, Rodrigo R, Orellana M et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci 2004;106:261-268.
16. Mathurin P, Gonzalez F, Kerdraon O et al. The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology 2006;130:1617-1624.
17. Elizondo A, Araya J, Rodrigo R et al. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease. Biol Res 2008;41:59-68.
18. Capanni M, Calella F, Biagini MR et al. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 2006;23:1143-1151.